AI in the Management of AMD from Clinical Trial to Real World
Time: 9:30 am
day: Conference Day Two
Details:
- The path of development, validation and regulatory approval for fully-automated algorithms
- Introduction of novel biomarkers and endpoints into clinical studies in the era of AI-empowered reading centers
- Using automated precision tools for screening, monitoring and prediction in clinical routine
